Cell-activatable CdSe fluorescence probe for dual-targeted imaging and drug application

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Cancer Research

Background:

• Targeted drug delivery systems are crucial for improving cancer therapy efficacy.
• Quantum dots offer unique optical properties for bioimaging.
• Folate receptors are overexpressed on various cancer cells, making them ideal targets.

Purpose of the Study:

• To develop a novel doxorubicin-quantum dots-folate nanoconjugate.
• To utilize the nanoconjugate as a fluorescence probe for targeted cancer cell imaging.
• To investigate the activatable fluorescence and cytotoxicity of the nanoconjugate within cancer cells.

Main Methods:

• Synthesis of a doxorubicin-quantum dots-folate nanoconjugate.
• Utilizing folate receptor-mediated endocytosis for targeted cellular uptake.
• Investigating glutathione-mediated dissociation of the nanoconjugate.
• Assessing fluorescence enhancement and cytotoxicity post-activation.

Main Results:

• The nanoconjugate successfully targeted and entered cancer cells via folate receptors.
• Intracellular glutathione triggered the dissociation and activation of the nanoconjugate.
• Activated nanoconjugate exhibited significantly enhanced fluorescence.
• Enhanced cellular toxicity was observed in cancer cells post-activation.

Conclusions:

• The doxorubicin-quantum dots-folate nanoconjugate serves as an effective fluorescence probe for targeted cancer imaging.
• The activatable nature of the nanoconjugate enhances both imaging and therapeutic potential.
• This platform shows promise for theranostic applications in cancer treatment.